Schonfeld Strategic Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-63,537	Closed	-$5.91M	–	3128
2021 Q4	$5.91M	Buy	63,537 +55,637	+704%	+$3.67M	0.05%	419
2021 Q3	$471K	Buy	+7,900	New	+$467K	﹤0.01%	1306
2021 Q1	–	Sell	-10,423	Closed	-$801K	–	2295
2020 Q4	$801K	Sell	10,423 -6,774	-39%	-$508K	0.01%	881
2020 Q3	$1.29M	Buy	+17,197	New	+$1.15M	0.02%	635
2018 Q4	–	Sell	-65,000	Closed	-$2.99M	–	1292
2018 Q3	$2.99M	Hold	65,000	–	–	0.13%	212
2018 Q2	$2.83M	Buy	65,000 +50,000	+333%	+$2.15M	0.15%	217
2018 Q1	$593K	Buy	+15,000	New	+$583K	0.04%	435

Schonfeld Strategic Advisors's ARNA Position: Q1 2022 in Review

Schonfeld Strategic Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 63,537 shares — an estimated $5.91M sold.

Schonfeld Strategic Advisors first reported a position in ARNA in Q1 2018 and held it in 7 quarters. The position peaked at $5.91M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Schonfeld Strategic Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 63,537 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5.91M.
Schonfeld Strategic Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 7 quarters.
Schonfeld Strategic Advisors's Arena Pharmaceuticals Inc position peaked at $5.91M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2022, filed 16 May 2022.